0001140361-18-014120.txt : 20180319
0001140361-18-014120.hdr.sgml : 20180319
20180319184220
ACCESSION NUMBER: 0001140361-18-014120
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180316
FILED AS OF DATE: 20180319
DATE AS OF CHANGE: 20180319
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lewicki John A.
CENTRAL INDEX KEY: 0001553352
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35993
FILM NUMBER: 18700187
MAIL ADDRESS:
STREET 1: C/O ONCOMED PHARMACEUTICALS, INC.
STREET 2: 800 CHESAPEAKE DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: OncoMed Pharmaceuticals Inc
CENTRAL INDEX KEY: 0001302573
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 383572512
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 800 CHESAPEAKE DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
BUSINESS PHONE: 650-995-8200
MAIL ADDRESS:
STREET 1: 800 CHESAPEAKE DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
4
1
doc1.xml
FORM 4
X0306
4
2018-03-16
0
0001302573
OncoMed Pharmaceuticals Inc
OMED
0001553352
Lewicki John A.
C/O ONCOMED PHARMACEUTICALS, INC.
800 CHESAPEAKE DRIVE
REDWOOD CITY
CA
94063
0
1
0
0
President & CEO
Stock Option (Right to Buy)
2.98
2018-03-16
4
A
0
125000
0.00
A
2028-03-15
Common Stock
125000
125000
D
The option vests with respect to 1/48 of the shares subject thereto on each monthly anniversary of March 16, 2018, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.
/s/ Alicia J. Hager, Attorney-in-Fact for John A. Lewicki
2018-03-19